Research Workers
Provide one-step panel/WES/WGS central lab servicefor clinical labs or other third parties
● >12 years medical NGS service experience (>600 employees)
● >600K rare disease patients diagnosed in China
● >5000 clinicians, >200 clinical labs serviced in China
● >Cloud based Al powered rare disease genomic reporting system (NuoYun)
Dr. Wu Jian
Founder and Chairman of MyGenostics
● BA, Chemical Biology, Peking University, China
● Ph.D, Genome Technology, Columbia University, USA
● Post Doc, Cancer Genetics, the Johns Hopkins University,USA
Core Technology - GenGap Gene Capture Technology
GenGap technology can capture human genome fragments flexibly and efficiently, combined with the next generation of high-throughput sequencing technology, it can be applied to large-scale gene research and screening.
1. One of the world's top three capture technology platforms, the earliest to realise deletion and duplication analysis through capture sequencing;
2. The earliest to use capture sequencing for genetic testing in China, effectively reducing sequencing costs;
3. The technology has reached the leading level in China,entered the stage of industrialization;
4. A platform for clinical mutation gene screening, diagnosis and personalized drug treatment genetic information was established in China.
Outstanding scientific research transformation ability
-National Key Research and Development Program of China - 3
-Major Project of the Ministry of Science and Technology - 2
-Special Project of the Ministry of Science and Technology - 1
-SCI Academic Papers - 924
-Patents - 39
-Software Copyright - 80
-Commercialization of Scientific and Research Findings Award - 4
CONTACT US
National Unified Hotline
400-003-5255
-
ꁸ 回到顶部
-
ꂅ 400-003-5255
-
ꁗ QQ客服
-
ꀥ 官方公众号